PFIZER INC Tax Adjustments, Settlements, and Unusual Provisions
PFIZER INC (PFE) reported Tax Adjustments, Settlements, and Unusual Provisions of $1.40 billion for the 3-month period ending 2010-12-31, per its 10-K filed 2011-02-28.
Discontinued › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2011-02-28
- PFIZER INC tax adjustments, settlements, and unusual provisions for the quarter ending 2010-12-31 was $1.40B.
- PFIZER INC tax adjustments, settlements, and unusual provisions for the quarter ending 2010-10-03 was -$50.00M.
- PFIZER INC tax adjustments, settlements, and unusual provisions for the quarter ending 2009-09-27 was -$174.00M.
- PFIZER INC tax adjustments, settlements, and unusual provisions for fiscal 2010 was $320.00M.
- PFIZER INC tax adjustments, settlements, and unusual provisions for fiscal 2008 was $305.00M.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|---|---|---|
| 2010-12-31 | $1.40B 10-K · filed 2011-02-28 | $1.35B derived: sum of 2 quarters · filed 2011-02-28 | $320.00M 10-K · filed 2011-02-28 | |
| 2010-10-03 | -$50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | -$460.00M 10-Q · filed 2010-11-12 | ||
| 2010-07-04 | -$410.00M 10-Q · filed 2010-08-12 | |||
| 2009-09-27 | -$174.00M 10-Q · filed 2010-11-12 | |||
| 2008-12-31 | $305.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |